Michael Putman, MD, MSCI
Assistant Professor
Locations
- Froedtert Hospital
- Rheumatology - Froedtert Hospital
Specialties
- Rheumatology
Languages
- English, Spanish
New & Established Patients Call
Education
- MD - Doctor of Medicine
- MSCI -Master of Science in Clinical Investigation
Biography
After graduating from Vanderbilt University in Nashville, TN, I returned to the Midwest for medical school at the University of Chicago, where I also completed a residency in internal medicine. From there I have migrated steadily northwards, first completing a year as Chief Resident at Mercy Hospital, a University of Chicago affiliate, and then pursuing a rheumatology fellowship at Northwestern University. I stayed on for an extra year to complete a T32 training grant, during which I developed a clinical and research focus in vasculitis.
Currently, I am doing the (much discouraged!) even split of patient care, research, and teaching. From a patient care perspective, I am the Medical Director of the Vasculitis Program, run the Fast Track GCA Clinic, and serve on the Innovative Therapies P&T committee. I also staff a general rheumatology clinic and have always been a generalist at heart! On the educational side, I am an Associate Program Director for both the rheumatology fellowship and the internal medicine residency. I am also the block director for the medical school hematology/immunology course and love teaching all levels of medical trainees. My research interests include clinical trials in vasculitis, “big data” epidemiology, and meta-research (i.e. researching research!). I am currently an Associate Editor of the journal Rheumatology and host the Evidence Based Rheumatology podcast.
In my off hours I like to spend time outdoors with my wife and three kids. I am also a hobby-enthusiast (always looking for another skill to learn!) and enjoy cooking, building things, and growing flowers/veggies in our gardens.
Publications
-
(Casey M, Pannu S, Bajwa S, Duarte-García A, Putman M.) Arthritis Care Res (Hoboken). 2024 Apr 03 PMID: 38570894 04/04/2024
-
(Figueroa-Parra G, Putman MS, Crowson CS, Duarte-García A.) Lupus Sci Med. 2024 Jan 10;11(1) PMID: 38199863 PMCID: PMC10806519 01/11/2024
-
(Gill B, Putman M.) Lancet Rheumatol. 2023 Dec;5(12):e698-e699 PMID: 38251556 01/22/2024
-
(Keller KK, Mukhtyar CB, Nielsen AW, Hemmig AK, Mackie SL, Sattui SE, Hauge EM, Dua A, Helliwell T, Neill L, Blockmans D, Devauchelle-Pensec V, Hayes E, Venneboer AJ, Monti S, Ponte C, De Miguel E, Matza M, Warrington KJ, Byram K, Yaseen K, Peoples C, Putman M, Lally L, Finikiotis M, Appenzeller S, Caramori U, Toro-Gutiérrez CE, Backhouse E, Oviedo MCG, Pimentel-Quiroz VR, Keen HI, Owen CE, Daikeler T, de Thurah A, Schmidt WA, Brouwer E, Dejaco C.) Ann Rheum Dis. 2023 Dec 01 PMID: 38050004 SCOPUS ID: 2-s2.0-85181942626 12/05/2023
-
Advocating for better trials in rheumatology.
(Kaushik S, Junek M, Putman M.) Rheumatology (Oxford). 2023 Dec 01;62(12):3776-3777 PMID: 37665753 SCOPUS ID: 2-s2.0-85178649487 09/04/2023
-
Unintentional unblinding in rheumatic disease trials.
(Bruggemeyer C, Nepal D, Putman M.) Lancet Rheumatol. 2023 Oct;5(10):e633-e636 PMID: 38251487 01/22/2024
-
Should race be considered in diagnosing giant cell arteritis? - Authors' reply.
(Gill T, Putman M, Sattui SE, Hamdulay S, Conway R, Liew DFL, Sharma A, Stone JH, Mackie SL, Mehta P.) Lancet Rheumatol. 2023 Jul;5(7):e372-e373 PMID: 38251547 01/22/2024
-
(Singla S, Putman M, Liew J, Gordon K.) Lancet Rheumatol. 2023 Jun;5(6):e313 PMID: 38251598 01/22/2024
-
(Singla S, Putman M, Liew J, Gordon K.) Lancet Rheumatol. 2023 Apr;5(4):e200-e207 PMID: 38251522 01/22/2024
-
Giant cell arteritis can occur in people of colour.
(Gill T, Putman M, Sattui SE, Hamdulay S, Conway R, Liew DFL, Sharma A, Stone JH, Mackie SL, Mehta P.) Lancet Rheumatol. 2023 Apr;5(4):e175-e177 PMID: 38251515 01/22/2024
-
Unintentional unblinding in rheumatic disease trials
(Bruggemeyer C, Nepal D, Putman M.) The Lancet Rheumatology. October 2023;5(10):e633-e636 SCOPUS ID: 2-s2.0-85171740217 10/01/2023